(16015810), N. J., (16015813), K. R. C., (14958336), H. H. M., (14942629), S. R., (16015816), C. T., (15038249), C. A. W., . . . (14942641), R. O. H. (2025). Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Cita Chicago Style (17a ed.)(16015810), Noor Jailkhani, et al. Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.
Cita MLA (9a ed.)(16015810), Noor Jailkhani, et al. Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.